Opexa Therapeutics is a publicly-traded cellular therapy company located in the Woodlands, TX (outside of Houston) with two proprietary, broad technical therapeutic platforms: T-cell vaccination and autologous stem cell therapy. Opexa Therapeutics is developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, cardiovascular disease, and diabetes.
Upcoming Webcasts
February 8, 2010
3:00 p.m. Eastern